Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT01575964

Biomechanical Assessment of Femoroacetabular Impingement

The purpose of this study is to determine the influence of FAI abnormalities on hip joint biomechanics.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year–35 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Utah Orthopaedic Center

Salt Lake City, Utah, 84108, United States

About this study

The purpose of this study is to quantify hip biomechanics of subjects with and without FAI.

The results of this study will advance our understanding of how the FAI alters the biomechanics of the hip joint, improving diagnosis and directing treatment strategies.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who present with hip pain subsequently diagnosed as femoroacetabular impingement
  • Subjects who meet the following radiographic criterion of cam or pincer FAI, will be given the opportunity to volunteer in this study.
  • Subjects that demonstrate a cross-over-sign or a lateral center edge angle (LCEA) without an alpha angle, will be classified as having pincer FAI.
  • Subjects with an alpha angle, without a cross-over sign or LCEA, will be categorized as having cam type FAI.
  • Finally, with at least one cam (alpha angle) and pincer sign "cross-over-sign or a lateral center edge angle (LCEA)" will be classified as mixed FAI.

Control Population Inclusion Criteria:

  • 12 controls will consist of volunteers in the same age range as the subject groups (18-35 years).
  • Control hips will be screened with a standard AP radiograph. Normal volunteers who have radiographic evidence of FAI, dysplasia or other joint deformities will be excluded.

Exclusion criteria

  • Subjects who have radiographic evidence of osteoarthritis (Tonnis Grade III or IV) will be excluded as this study focuses on the mechanics of hips before prominent cartilage damage.
  • Subjects who have had prior procedures to correct FAI or other hip conditions will be excluded (exploratory procedures will be included).
  • Minors (under age 18), mentally disabled, persons incarcerated, on parole, probation awaiting trial, or pregnant women are excluded from this study.
  • A human Chorionic Gondaotropin (hCG) urine pregnancy test will be performed on all women prior to the study.
  • To limit the annual radiation exposure to any participating volunteers, we will exclude anyone who has had a CT scan or participated in a research study involving ionizing radiation in the past 12 months.

Motion Capture Exclusion Criteria:

  • Subjects who are unwilling or unable to perform the proposed activities of daily living or undergo the clinical exams will be dismissed.
  • Subjects with a BMI less than 30 (www.nhlbisupport.com/bmi/) or those with dense hip musculature/wide hips (maximum of 42 cm of circumferential hip length) will be excluded.

CT Exclusion Criteria:

  • Subjects who are unwilling or unable to remain still.
  • Subjects who are allergic to contrast agent and/or lidocaine will be dismissed.

Treatment and study plan

Primary outcomes

  1. Data Collection

    Time frame: Follow-up Visit

    We will calculate hip joint kinematics. Statistical analysis of the results will allow comparisons between normal and FAI subjects.

Sponsors and collaborators

Lead sponsor

University of Utah

Other

Registry information

Acronym: FAI

Important dates

Study start
2012
Primary completion
2028
Study completion
2028
First posted
Apr 12, 2012
Registry last updated
Jan 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.